# Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

> **NCT00193661** · PHASE2 · COMPLETED · sponsor: **Solvay Pharmaceuticals**

## Conditions studied

- Primary or Secondary Hypogonadism
- Constitutional Delay in Growth and Puberty (CDGP)

## Interventions

- **DRUG:** Testosterone Gel (1%)

## Key facts

- **NCT ID:** NCT00193661
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** — (—)
- **Last updated:** 2015-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00193661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00193661, "Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00193661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*